Скачать или смотреть Breakthrough mRNA Therapy Targets Drug-Resistant Pneumonia – Hope Against Superbugs

Discover the latest in mRNA therapy for antibiotic-resistant pneumonia. This innovative treatment uses mRNA to produce bacteria-killing 'peptibodies,' showing promising results in preclinical models.
In this video, we dive into the groundbreaking research from the Icahn School of Medicine at Mount Sinai. Learn how this therapy slows bacterial growth, boosts immune responses, and reduces lung damage in studies with mice and human lung tissue.
Antibiotic resistance is a global crisis, causing over 1.2 million deaths yearly. This mRNA approach, delivered via lipid nanoparticles, could revolutionize treatment for multidrug-resistant infections like Staphylococcus aureus and Pseudomonas aeruginosa.
Hear from experts like Dr. Xucheng Hou and Dr. Dong on how peptibodies disrupt bacteria and enhance immunity. While still in early stages, this could lead to new ways to support antibiotics.
Explore the science behind nanomedicine, immunology, and drug delivery in fighting superbugs. Stay updated on the path to clinical trials and future therapeutics.